Robert W. Baird Has Lowered Expectations for Dolby Laboratories (NYSE:DLB) Stock Price

Dolby Laboratories logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Robert W. Baird cut its Dolby Laboratories price target from $62 to $60 and maintained a Neutral rating, implying 5.49% upside from the prior close. Analysts overall rate the stock Hold, with a consensus target of $76.67.
  • Dolby reported quarterly EPS of $1.25, beating the $1.20 consensus, while revenue rose 21.7% year over year to $373.54 million and also topped estimates.
  • The company has authorized a $350 million share buyback, allowing it to repurchase up to 7% of its shares.
  • Interested in Dolby Laboratories? Here are five stocks we like better.

Dolby Laboratories (NYSE:DLB - Get Free Report) had its price objective reduced by analysts at Robert W. Baird from $62.00 to $60.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has a "neutral" rating on the electronics maker's stock. Robert W. Baird's price objective points to a potential upside of 5.49% from the company's previous close.

Several other research analysts have also commented on the stock. Rosenblatt Securities lowered their price objective on shares of Dolby Laboratories from $85.00 to $80.00 and set a "buy" rating for the company in a research note on Monday. Zacks Research upgraded shares of Dolby Laboratories from a "strong sell" rating to a "hold" rating in a report on Friday, November 13th. Wall Street Zen downgraded shares of Dolby Laboratories from a "buy" rating to a "hold" rating in a research note on Saturday, August 1st. Finally, Weiss Ratings upgraded shares of Dolby Laboratories from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, September 9th. Two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Dolby Laboratories presently has an average rating of "Hold" and a consensus target price of $76.67.

Get Our Latest Research Report on Dolby Laboratories

Dolby Laboratories Stock Down 3.3%

Shares of Dolby Laboratories stock opened at $56.88 on Thursday. The firm has a market cap of $5.33 billion, a PE ratio of 21.07 and a beta of 0.79. Dolby Laboratories has a 52 week low of $48.26 and a 52 week high of $69.95. The business's fifty day simple moving average is $60.80 and its 200-day simple moving average is $59.37.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its earnings results on Tuesday, November 17th. The electronics maker reported $1.25 EPS for the quarter, beating analysts' consensus estimates of $1.20 by $0.05. Dolby Laboratories had a return on equity of 11.78% and a net margin of 18.14%. The company had revenue of $373.54 million during the quarter, compared to analysts' expectations of $372.76 million. During the same period last year, the business posted $0.99 EPS. Dolby Laboratories's revenue for the quarter was up 21.7% on a year-over-year basis. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. As a group, equities analysts expect that Dolby Laboratories will post 3.36 earnings per share for the current year.

Dolby Laboratories declared that its board has approved a stock buyback program on Thursday, July 30th that authorizes the company to repurchase $350 million in shares. This buyback authorization authorizes the electronics maker to repurchase up to 7% of its stock through open market purchases. Share buyback programs are usually an indication that the company's board of directors believes its shares are undervalued.

Insider Activity

In other Dolby Laboratories news, CAO Ryan Nicholson sold 1,183 shares of the stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total value of $77,226.24. Following the sale, the chief accounting officer owned 34,453 shares of the company's stock, valued at $2,249,091.84. This trade represents a 3.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP John Couling sold 7,667 shares of the stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $58.78, for a total value of $450,666.26. Following the completion of the sale, the senior vice president directly owned 166,803 shares in the company, valued at $9,804,680.34. This represents a 4.39% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 16,517 shares of company stock worth $995,963. 37.93% of the stock is owned by company insiders.

Institutional Trading of Dolby Laboratories

Several hedge funds have recently added to or reduced their stakes in DLB. Bank of New York Mellon Corp acquired a new position in Dolby Laboratories during the 2nd quarter worth approximately $253,289,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in shares of Dolby Laboratories in the 3rd quarter valued at $40,429,000. Advisors Asset Management Inc. acquired a new stake in shares of Dolby Laboratories in the 3rd quarter valued at $34,670,000. First Trust Advisors LP raised its holdings in shares of Dolby Laboratories by 19.9% in the 1st quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker's stock valued at $135,431,000 after purchasing an additional 374,405 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC acquired a new stake in shares of Dolby Laboratories in the 3rd quarter valued at $13,622,000. Institutional investors and hedge funds own 58.56% of the company's stock.

More Dolby Laboratories News

These are some of the DLB news items that stood out recently:

  • Positive Sentiment: Fiscal Q4 revenue was $373.5 million, up 21.7% year over year, and EPS of $1.25 beat consensus estimates. Zacks Research also made small upward revisions to several future EPS forecasts. Dolby Q4 earnings and revenue surpass estimates
  • Positive Sentiment: Dolby raised its quarterly dividend 8.3%, from $0.36 to $0.39 per share, equivalent to $1.56 annually. The company also noted that advanced audio and imaging patents generated more than half of licensing revenue, while its Video Distribution Patent Program grew to 47 licensors. Dolby: 3 key takeaways for long-term investors
  • Negative Sentiment: Analysts trimmed price targets: Barrington lowered its target from $90 to $80 but kept an Outperform rating, while Rosenblatt cut its target from $85 to $80 and retained a Buy rating. DLB also slipped below its 200-day moving average after an analyst downgrade, adding technical pressure. Barrington cuts Dolby price target

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

Featured Articles

Analyst Recommendations for Dolby Laboratories (NYSE:DLB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines